Translations:Diabetes medication/20/en

Typical reductions in glycated hemoglobin (A1C) values are 1.5–2.0%. Some examples are:

• Rosiglitazone (Avandia): the European Medicines Agency recommended in September 2010 that it be suspended from the EU market due to elevated cardiovascular risks.
• Pioglitazone (Actos): remains on the market but has also been associated with increased cardiovascular risks.
• Troglitazone (Rezulin): used in 1990s, withdrawn due to hepatitis and liver damage risk.